You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Borderline resectable pancreatic adenocarcinoma

Showing 1 - 25 of 6,427
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreas Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Adenocarcinoma Trial in

Not yet recruiting
  • Pancreas Adenocarcinoma
  • +2 more
  • Nab paclitaxel
  • +3 more
  • Winston-Salem, North Carolina
    Wake Forest Baptist Comprehensive Cancer Center
Apr 19, 2023

Pancreatic Adenocarcinoma Trial in Dublin (Dose-Painted Intensity Modulated Radiotherapy)

Not yet recruiting
  • Pancreatic Adenocarcinoma
  • Dose-Painted Intensity Modulated Radiotherapy
  • Dublin, Ireland
    St Luke's Radiation Oncology Network (SLRON)
Aug 29, 2023

Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

Suspended
  • Borderline Resectable Pancreatic Cancer
  • Intraoperative radiotherapy
  • Verona, Italy
    General and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Ductal

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +3 more
  • Hafnium Oxide-containing Nanoparticles NBTXR3
  • Radiation Therapy
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Pancreatic Cancer, Pancreatic Adenocarcinoma, Pancreas Ductal Adenocarcinoma Trial in United States (Nab-paclitaxel and

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Nab-paclitaxel and gemcitabine for R-PDAC Patients
  • Nab-paclitaxel and gemcitabine for BR-PDAC Patients
  • Scottsdale, Arizona
  • +3 more
Mar 8, 2022

Pancreatic Adenocarcinoma Trial in Hamilton (mFOLFIRINOX, Gemcitabine / Nab-paclitaxel)

Recruiting
  • Pancreatic Adenocarcinoma
  • Hamilton, Ontario, Canada
    Juravinski Hospital
Aug 5, 2022

Borderline Resectable Pancreatic Adenocarcinoma, Resectable Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer AJCC v8 Trial

Recruiting
  • Borderline Resectable Pancreatic Adenocarcinoma
  • +5 more
  • Durvalumab
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Survival, Quality of Life and Resectability in Locally Advanced

Recruiting
  • Pancreas Cancer
  • +8 more
    • Umeå, Sweden
      Surgical Clinic at Umeå University Hospital
    Nov 23, 2022

    Untreated Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic

    Recruiting
    • Untreated Resectable Pancreatic Adenocarcinoma
    • +2 more
    • Paclitaxel protein bound
    • +3 more
    • Scottsdale, Arizona
      HonorHealth Research Institute
    May 10, 2022

    Chemo Effect, Pancreas Cancer Trial in Barcelona (Neoadyuvant therapy)

    Not yet recruiting
    • Chemotherapy Effect
    • Pancreas Cancer
    • Neoadyuvant therapy
    • Barcelona, Spain
      Hospital del Mar
    Aug 23, 2022

    Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles

    Not yet recruiting
    • Borderline Resectable Pancreatic Adenocarcinoma
    • Locally Advanced Pancreatic Ductal Adenocarcinoma
    • Biospecimen Collection
    • +9 more
    • Los Angeles, California
      Yonemoto,Lisa
    Jan 13, 2023

    Predictive Factors for Resection and Survival in Type A

    Not yet recruiting
    • Carcinoma, Pancreatic Ductal
    • Resection
    • No Resection
    • (no location specified)
    Aug 3, 2022

    Pancreas Cancer Trial in New York (Bethanechol, Gemcitabine, nab-paclitaxel)

    Recruiting
    • Pancreas Cancer
    • New York, New York
      Columbia University Medical Center
    Feb 3, 2022

    Resectable or Locally Advanced Borderline Pancreatic

    Active, not recruiting
    • Pancreas Cancer
    • Adenocarcinoma
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Aug 19, 2022

      Surgery After Neoadjuvant Chemotherapy in Locally Advanced

      Completed
      • Postoperative Complications
      • surgery after neoadjuvant chemotherapy
      • Seoul, Korea, Republic of
        Asan medical center
      Jun 1, 2023

      Pancreatic Ductal Adenocarcinoma Trial in Saint Louis (BMS-813160, Nivolumab, Gemcitabine)

      Active, not recruiting
      Has Results
      • Pancreatic Ductal Adenocarcinoma
      • Saint Louis, Missouri
        Washington University School of Medicine
      Dec 8, 2022

      Pancreatic Tumor Trial in Brussels (mFOLFIRINOX or gemcitabine-nabpaclitaxel)

      Not yet recruiting
      • Pancreatic Neoplasm
      • mFOLFIRINOX or gemcitabine-nabpaclitaxel
      • Brussels, Belgium
        Hopital Erasme
      Oct 15, 2021

      Pancreatic Cancer Trial in Baltimore, Milwaukee (Cyclophosphamide, Nivolumab, GVAX Pancreas Vaccine)

      Active, not recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
      • +1 more
      Mar 3, 2022

      Resectable Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma Trial (Stereotactic Ablative Body

      Not yet recruiting
      • Resectable Pancreatic Adenocarcinoma
      • Borderline Resectable Pancreatic Adenocarcinoma
      • Stereotactic Ablative Body Radiotherapy (SABR)
      • (no location specified)
      Jun 16, 2021

      Pancreatic Cancer Trial in Baltimore (Cyclophosphamide, GVAX, Pembrolizumab)

      Active, not recruiting
      • Pancreatic Cancer
      • Baltimore, Maryland
        Sidney Kimmel Comprehensive Cancer Center
      Jan 5, 2023

      Pancreatic Adenocarcinoma Trial in Los Angeles (Pancrelipase)

      Recruiting
      • Pancreatic Adenocarcinoma
      • Los Angeles, California
        Cedars-Sinai Medical Center
      Jul 15, 2022

      Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal

      Recruiting
      • Borderline Resectable Pancreatic Adenocarcinoma
      • +11 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Mar 22, 2022

      Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

      Recruiting
      • Borderline Resectable Pancreatic Carcinoma
      • +8 more
      • Portland, Oregon
        OHSU Knight Cancer Institute
      Aug 25, 2022

      Pancreatic Ductal Adenocarcinoma Trial in United States (NALIRIFOX, AD-XRT and Capecitabine)

      Recruiting
      • Pancreatic Ductal Adenocarcinoma
      • Basking Ridge, New Jersey
      • +6 more
      May 15, 2023